Healthcare Services

Human Growth Hormone Market Size Outlook and Demand Growth Across 2026–2030

April 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Growth Is Projected For The Human Growth Hormone Market During The Forecast Period 2026–2030?

The human growth hormone market has experienced substantial expansion recently. Forecasts indicate it will expand from $5.18 billion in 2025 to reach $5.68 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 9.5%. This historical growth is attributable to factors such as a rise in the diagnosis of growth hormone deficiency, the broadening of recombinant hormone production, increased recognition of pediatric growth disorders, the greater accessibility of branded hgh therapies, and the established clinical application of hormone replacement.

The human growth hormone market is projected to experience substantial expansion in the upcoming years. This market is forecast to reach $7.87 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.5%. Factors contributing to this growth during the projection period include a rising demand for extended-release growth hormone treatments, the increasing occurrence of adult growth hormone deficiency, a heightened emphasis on individualized endocrine care, the expansion of specialty pharmacy networks, and increased funding for hormone therapy investigations. Key trends anticipated during this period encompass a growing need for treatments addressing growth hormone deficiency, greater uptake of sustained-release growth hormone preparations, expanded application of HGH in pediatric endocrinology, broader availability of recombinant growth hormone therapies, and an enhanced focus on patient compliance and ease of administration.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15825&type=smp

Which Economic Or Industry Drivers Are Impacting The Human Growth Hormone Market?

The human growth hormone market is expected to experience growth driven by the increasing aging population. This demographic shift involves a growing proportion of older individuals within a society, a phenomenon attributed to both longer life expectancy and declining birth rates. Advances in healthcare that have extended life expectancy are a key factor contributing to the rise in the aging population. Human growth hormone is utilized by older adults under medical supervision to address age-related issues such as muscle loss, reduced energy, and metabolic decline. For example, in January 2024, the Population Reference Bureau, a US-based non-profit organization, reported that the number of Americans aged 65 and older is projected to increase from 58 million in 2022 to 82 million by 2050, signifying a 47% rise. Consequently, this age group’s share of the total U.S. population will grow from 17% to 23% during this period. Therefore, the expanding aging population is fueling the growth of the human growth hormone market. The rising healthcare expenditure is anticipated to propel the growth of the human growth hormone market going forward. Healthcare expenditure encompasses the total spending on health services, products, and interventions aimed at improving and maintaining health. Human growth hormone (HGH) therapy provides a unique method to potentially reduce healthcare expenditure by targeting underlying health issues that contribute to long-term costs, enhancing recovery and quality of life, and potentially mitigating the onset of costly chronic conditions. For instance, in May 2023, a report published by the Office for National Statistics, a UK-based government department, indicated that healthcare spending in the UK increased by 5.6% between 2022 and 2023, which contrasts with a 0.9% growth in 2022. The total UK healthcare expenditure was approximately $317.63 billion (£292 billion) in 2023. Consequently, the increasing healthcare expenditure is driving the human growth hormone market.

What Market Segments Are Evaluated Within The Human Growth Hormone Market?

The human growth hormone market covered in this report is segmented –

1) By Product: Liquid, Powder

2) By Brand: Norditropin, Genotropin, Humatrope, Saizen, Omnitrope, Skytrofa, Other Brands

3) By Route Of Administration: Intramuscular, Subcutaneous

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacy, Specialty Pharmacy

5) By Application: Growth Hormone (GH) Deficiency, Adult Growth Hormone (GH) Deficiency, Pediatric Growth Hormone (GH) Deficiency, Turner Syndrome, Idiopathic Short Stature, Prader-Willi Syndrome, Small For Gestational Age, Other Applications

Subsegments:

1) By Liquid: Pre-Filled Liquid Syringes, Vials Of Liquid Growth Hormone

2) By Powder: Reconstitutable Powder, Freeze-Dried Powder

What Trends Are Projected To Affect The Human Growth Hormone Market?

Leading companies in the human growth hormone market are intensifying their efforts in drug development and securing approvals to advance their medication offerings and provide improved treatment options. Developing new drugs is an intricate and demanding process, comprising numerous stages to assure the safety, effectiveness, and quality of a novel drug before its market release. For example, in June 2023, Pfizer Inc., a US-based biopharmaceutical company, along with OPKO Health Inc., another US-based biopharmaceutical and diagnostics company, declared the Food and Drug Administration (FDA) approval of NGENLA (somatrogon-ghla). This particular treatment provides a more convenient dosing schedule and enhances patient adherence compared to daily injections. It offers children with growth hormone deficiency the opportunity to reduce their injection frequency from daily to just once a week. The FDA’s approval was bolstered by a Phase 3 study, which established NGENLA’s non-inferiority when measured against once-daily somatropin, and confirmed a safety profile consistent with somatropin.

Who Are The Top Market Participants Influencing The Human Growth Hormone Market?

Major companies operating in the human growth hormone market are Pfizer Inc., Roche Holding AG, Novartis AG, Thermo Fisher Scientific Inc., Eli Lilly and Company, Novo Nordisk A/S, Merck KGaA, Teva Pharmaceutical Industries Ltd., Sandoz International GmbH, Ipsen Pharma, Ferring Holding SA, Endo International, Zydus Lifesciences Limited, Opko Health, LG Life Sciences, EMD Serono Inc., Wockhardt Ltd., JCR Pharmaceuticals Co. Ltd., Genentech Inc., SOFAR S.p.A., United Laboratories, Ascendis Pharma, Uni-Pharma S.A., Versartis Inc., Reliance Life Sciences, Anhui Anke Biotechnology (Group) Co. Ltd., Rani Therapeutics

Read the full human growth hormone market report here:

https://www.thebusinessresearchcompany.com/report/human-growth-hormone-global-market-report

What Are The Top-Performing Regions Within The Human Growth Hormone Market?

North America was the largest region in the human growth hormone market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the human growth hormone market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Human Growth Hormone Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=15825&type=smp

Browse Through More Reports Similar to the Global Human Growth Hormone Market 2026, By The Business Research Company

Hormone Therapy Global Market Report

https://www.thebusinessresearchcompany.com/report/hormone-therapy-global-market-report

Bioidentical Hormones Global Market Report

https://www.thebusinessresearchcompany.com/report/bioidentical-hormones-global-market-report

Bone Growth Stimulator Global Market Report

https://www.thebusinessresearchcompany.com/report/bone-growth-stimulator-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795